Participation of cytochromes P4502B and P4503A in cocaine toxicity in rat hepatocytes

Drug Metabolism and Disposition

Volumn 24, Issue 1, 1996, Pages 74-80

  Poet, Torka S ^a,b   Mcqueen, Charlene A ^a   Halpert, James R ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; CHLORAMPHENICOL; COCAINE; CYTOCHROME P450; DEXAMETHASONE; LACTATE DEHYDROGENASE; N DEMETHYLASE; NORCOCAINE; PHENOBARBITAL; TROLEANDOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DRUG OXIDATION; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; GUINEA PIG; HUMAN; HUMAN CELL; HYDROXYLATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER MICROSOME; LIVER TOXICITY; LYMPHOBLASTOID CELL; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT; RAT; XENOBIOTIC METABOLISM;

ANIMALS; CELL LINE; CELLS, CULTURED; COCAINE; CYTOCHROME P-450 ENZYME SYSTEM; DEXAMETHASONE; DOGS; ENZYME INDUCTION; GUINEA PIGS; HUMANS; HYDROXYLATION; ISOENZYMES; MALE; MICROSOMES, LIVER; PHENOBARBITAL; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY;

ANIMALIA; CANIS FAMILIARIS; CAVIA; CAVIA PORCELLUS; ORYCTOLAGUS CUNICULUS; SUS SCROFA;

EID: 0030043207     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. F. P. Guengerich and T Shimada: Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 4, 391-401 (1991).
2. D. R. Nelson, T. Kamataki, D. J. Waxman, F. P. Guengerich, R. W. Estabrook, F. Feyereisen, F. J. Gonzalez, M. J. Coon, I. C. Gunsalus, O. Gotoh, K. Okuda, and D. W Nebert: The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 12, 1-51 (1993).
3. M. J. Coon, X. Ding, S. J. Pernecky, and A. D. N. Vaz: Cytochrome P450: progress and predictions. FASEB J. 6, 669-673 (1992).
4. F. J. Gonzalez and H. V. Gelboin: Role of human cytochrome P-450s in risk assessment and susceptibility to environmentally based disease. J. Toxicol. Environ. Health 40, 289-308 (1993).
5. J. R. Halpert: Structural basis of selective cytochrome P450 inhibition. Ann. Rev. Pharm. Toxicol. 35, 29-35 (1995).
6. A. R. Dahl and W. M. Hadley: Nasal cavity enzymes involved in xenobiotic metabolism: effects on toxicity of inhalants. CRC Crit. Rev. Toxicol. 21, 345-372 (1991).
7. E. G. Schuetz, S. A. Wrighton, S. H. Safe, and P. S. Guzelian: Regulation of cytochrome P-450p by phenobarbital and phenobarbital-like inducers in adult rat hepatocytes in primary monolayer culture and in vivo. Biochemistry 25, 1124-1133 (1986).
8. F. J. Gonzalez, B.-J Song, and J. P. Hardwick: Pregnenolone 16α-carbonitrile-inducible P-450 gene family: gene conversion and differential regulation. Mol. Cell. Biol. 6, 2969-2976 (1986).
9. M. L. Thompson, L. Shuster, and E. Casey: Sex and strain differences in response to cocaine. Biochem. Pharmacol. 33, 1299-1307 (1984).
10. C. J. Henderson and C. R. Wolf: Molecular analysis of cytochrome P450s in the CYP2 gene family. In "Progress in Drug Metabolism" (G. G. Gibson, ed.), vol. 13, pp. 73-139. Taylor and Francis, London, 1992.